Literature DB >> 34112182

Inflammatory signaling mechanisms in bipolar disorder.

Gregory H Jones1, Courtney M Vecera2, Omar F Pinjari2, Rodrigo Machado-Vieira2.   

Abstract

Bipolar disorder is a decidedly heterogeneous and multifactorial disease, with a high individual and societal burden. While not all patients display overt markers of elevated inflammation, significant evidence suggests that aberrant immune signaling contributes to all stages of the disease, and likely explains the elevated rates of comorbid inflammatory illnesses seen in this population. While individual systems have been intensely studied and targeted, a relative paucity of attention has been given to the interconnecting role of inflammatory signals therein. This review presents an updated overview of some of the most prominent pathophysiologic mechanisms in bipolar disorder, from mitochondrial, endoplasmic reticular, and calcium homeostasis, to purinergic, kynurenic, and hormonal/neurotransmitter signaling, showing inflammation to act as a powerful nexus between these systems. Several areas with a high degree of mechanistic convergence within this paradigm are highlighted to present promising future targets for therapeutic development and screening.

Entities:  

Keywords:  BDNF; Bipolar; Glutamate; Inflammation; Mitochondria; NLRP3; P2X7; Purine

Year:  2021        PMID: 34112182     DOI: 10.1186/s12929-021-00742-6

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  161 in total

1.  Neurocognitive functioning in the prodrome of mania--an exploratory study.

Authors:  Aswin Ratheesh; Ashleigh Lin; Barnaby Nelson; Stephen J Wood; Warrick Brewer; Jennifer Betts; Michael Berk; Patrick McGorry; Alison R Yung; Andreas Bechdolf
Journal:  J Affect Disord       Date:  2012-11-08       Impact factor: 4.839

2.  General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases.

Authors:  Giulio Perugi; Giuseppe Quaranta; Serena Belletti; Francesca Casalini; Nicola Mosti; Cristina Toni; Liliana Dell'Osso
Journal:  J Affect Disord       Date:  2014-09-06       Impact factor: 4.839

3.  Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders.

Authors:  Benjamin I Goldstein; Katelyn A Collinger; Francis Lotrich; Anna L Marsland; Mary-Kay Gill; David A Axelson; Boris Birmaher
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-10       Impact factor: 2.576

Review 4.  Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems.

Authors:  Ana SayuriYamagata; Elisa Brietzke; Joshua D Rosenblat; Ron Kakar; Roger S McIntyre
Journal:  J Affect Disord       Date:  2017-01-04       Impact factor: 4.839

5.  Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment.

Authors:  Vesile Uyanik; Cengiz Tuglu; Yasemin Gorgulu; Hakan Kunduracilar; Mehmet Sevki Uyanik
Journal:  Psychiatry Res       Date:  2015-06-27       Impact factor: 3.222

Review 6.  Areas of controversy in neuroprogression in bipolar disorder.

Authors:  I C Passos; B Mwangi; E Vieta; M Berk; F Kapczinski
Journal:  Acta Psychiatr Scand       Date:  2016-04-21       Impact factor: 6.392

Review 7.  A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.

Authors:  Rushaniya A Khairova; Rodrigo Machado-Vieira; Jing Du; Husseini K Manji
Journal:  Int J Neuropsychopharmacol       Date:  2009-02-19       Impact factor: 5.176

8.  Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder.

Authors:  S G Fillman; D Sinclair; S J Fung; M J Webster; C Shannon Weickert
Journal:  Transl Psychiatry       Date:  2014-02-25       Impact factor: 6.222

9.  Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses.

Authors:  Tobias Rowland; Benjamin I Perry; Rachel Upthegrove; Nicholas Barnes; Jayanta Chatterjee; Daniel Gallacher; Steven Marwaha
Journal:  Br J Psychiatry       Date:  2018-09       Impact factor: 9.319

View more
  6 in total

1.  No NLRP3 Inflammasome Expression in the Ouabain Animal Model of Bipolar Disorder.

Authors:  Ali A Farooqui; Yonglin Gao; Megan A Coghlan; Rifaat S El-Mallakh
Journal:  Cureus       Date:  2022-05-05

Review 2.  Potentiating the Benefits of Melatonin through Chemical Functionalization: Possible Impact on Multifactorial Neurodegenerative Disorders.

Authors:  Annia Galano; Eduardo G Guzmán-López; Russel J Reiter
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 3.  Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress-Induced Damage in Patients with Bipolar Disorder.

Authors:  Sahithi Madireddy; Samskruthi Madireddy
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

Review 4.  Blood-brain barrier dysfunction in bipolar disorder: Molecular mechanisms and clinical implications.

Authors:  Ning O Zhao; Natasha Topolski; Massimo Tusconi; Erika M Salarda; Christopher W Busby; Camila N N C Lima; Anilkumar Pillai; Joao Quevedo; Tatiana Barichello; Gabriel R Fries
Journal:  Brain Behav Immun Health       Date:  2022-03-05

Review 5.  The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder.

Authors:  Maria Carolina Bittencourt Gonçalves; Roberta Andrejew; Carolina Gubert
Journal:  CNS Drugs       Date:  2022-07-13       Impact factor: 6.497

6.  Long-term effect of childhood trauma: Role of inflammation and white matter in mood disorders.

Authors:  Sara Poletti; Marco Paolini; Julia Ernst; Irene Bollettini; Elisa Melloni; Benedetta Vai; Yasmin Harrington; Beatrice Bravi; Federico Calesella; Cristina Lorenzi; Raffaella Zanardi; Francesco Benedetti
Journal:  Brain Behav Immun Health       Date:  2022-10-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.